J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 7.13 CNY -0.14% Market Closed
Market Cap: 8B CNY
Have any thoughts about
Jinyu Bio-Technology Co Ltd?
Write Note

Jinyu Bio-Technology Co Ltd
Unrealized Security Profit/Loss

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinyu Bio-Technology Co Ltd
Unrealized Security Profit/Loss Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Unrealized Security Profit/Loss CAGR 3Y CAGR 5Y CAGR 10Y
J
Jinyu Bio-Technology Co Ltd
SSE:600201
Unrealized Security Profit/Loss
ÂĄ24.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Unrealized Security Profit/Loss
ÂĄ9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Unrealized Security Profit/Loss
-ÂĄ117.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Unrealized Security Profit/Loss
ÂĄ2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jinyu Bio-Technology Co Ltd
Glance View

Market Cap
8B CNY
Industry
Biotechnology

Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.

Intrinsic Value
10.74 CNY
Undervaluation 34%
Intrinsic Value
Price
J

See Also

What is Jinyu Bio-Technology Co Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
24.2m CNY

Based on the financial report for Sep 30, 2024, Jinyu Bio-Technology Co Ltd's Unrealized Security Profit/Loss amounts to 24.2m CNY.

Back to Top